NDC 33332-025-04 - Afluria
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33332-025
- Requested NDC
- 33332-025-04
- Package NDCs from labels
- 33332-025-04, 33332-025-03
- Manufacturer
- Seqirus PTY LTD. | Seqirus Pty Ltd, Australia | CSL Behring GmbH, Germany
- Effective date
- 2026-03-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Afluria - Seqirus PTY LTD. | Seqirus Pty Ltd, Australia | CSL Behring GmbH, Germany | Seqirus PTY LTD. | Seqirus Pty Ltd, Australia | CSL Behring GmbH, Germany | 2026-03-09 | VACCINE LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33332-025-03 | Afluria | 10 in 1 CARTON | INJECTION, SUSPENSION | 10 | 16 | |
| 33332-025-04 | Afluria | 0.5 mL in 1 SYRINGE, GLASS | INJECTION, SUSPENSION | 0.5 | 16 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33332-025-03 | ML - Milliliter | 33332-025 | 03d5868d-fc1f-4194-a127-9d37503b2573 | 1 | 2025-08-11 |
| 33332-025-04 | ML - Milliliter | 33332-025 | e918c324-f8c4-463f-a73d-08718de7f155 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| K Phos Neutral | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Beach Products, Inc. | 83376725-ee0f-40ad-bd90-31a61b9445cf | 2023-02-23 | Adverse reactions | 22ADO53M6F 4J9FJ0HL51 |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 1ef4a040-7bee-11e6-8371-424c58303031 | 2023-02-20 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645e304-a71b-5cba-e053-2a91aa0a2d88 | 2023-02-20 | 451W47IQ8X | |
| EyeClear Pro | CALC CARB, CALC FLUOR, CAUSTICUM, CINERARIA, EUPHRASIA, NAPHTHALINUM, NAT MUR, PHOS, QUASSIA, SILICEA | Silver Star Brands | f4d4943b-cb78-aa71-e053-2a95a90ac638 | 2023-02-16 | Warnings | 451W47IQ8X |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 87cc7349-5a07-4a39-be97-4e1013814f30 | 2023-02-06 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 9f8d2886-9ecd-4cbf-a84a-2d221cb3497c | 2023-01-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86463b98-58f5-7f65-e053-2a91aa0ad3a2 | 2023-01-23 | 451W47IQ8X | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608d5a3-93e6-e8e2-e053-2a91aa0aaedc | 2023-01-23 | 660YQ98I10 | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645f130-6a19-ae73-e053-2991aa0ab05b | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645eb60-65d1-9d6c-e053-2991aa0a94ef | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8644ffef-f0e6-5c06-e053-2a91aa0ae83d | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86466614-b8ee-2335-e053-2a91aa0aa67c | 2023-01-23 | 451W47IQ8X | |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| PSORIASIS | ARSENICUM ALBUM, ARSENICUM IODATUM, BORAX, CALCAREA CARBONICA, GRAPHITES, MEZEREUM, PROTEUS, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, SEPIA, SILICEA, SULPHUR, THYROIDINUM | Zorex International | b5b8bb82-4d36-4faa-b023-e48066f4521c | 2023-01-09 | Warnings | 451W47IQ8X |
| Kali Mur | KALI MURIATICUM | Energique, Inc. | db9894e6-2de0-428e-b553-11bb39a1d711 | 2023-01-04 | Warnings | 660YQ98I10 |
| Virimmune | ALLIUM SATIVUM, ECHINACEA (ANGUSTIFOLIA), GINKGO BILOBA, VISCUM ALBUM, HAMAMELIS VIRGINIANA, ACONITUM NAPELLUS, ALLIUM CEPA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, CHELIDONIUM MAJUS, GELSEMIUM SEMPERVIRENS, MERCURIUS VIVUS, NATRUM MURIATICUM, NUX VOMICA, SELENIUM METALLICUM, INFLUENZINUM (2021-2022), MORBILLINUM | Deseret Biologicals, Inc. | 56555cb5-89e5-4a30-8ebe-ce2c01bdd426 | 2023-01-03 | Warnings | 451W47IQ8X |
| AILGENO | AMANITA MUSCARIA FRUITING BODY, ARSENIC TRIOXIDE, MILK THISTLE, CEANOTHUS AMERICANUS LEAF, CINCHONA OFFICINALIS BARK, GLECHOMA HEDERACEA FLOWERING TOP, GRINDELIA HIRSUTULA WHOLE, AND SODIUM CHLORIDE | PEKANA Naturheilmittel GmbH | 4e24f727-4c83-46b6-9549-8f66bd135647 | 2022-12-21 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.